Back

prof. dr. E. (E) van der Wall

prof. dr. E. (E) van der Wall

Full Professor
prof. dr. E. (E) van der Wall
  • Strategic theme Cancer

Research Programs

Strategic Program Cancer

Biography

Biography

Elsken van der Wall (1960)  has studied medicine at the University of Utrecht and subsequently specialized in internal medicine at the University Medical Center of Utrecht.

In the Dutch Cancer Institute / Het Antoni van Leeuwenhoekhuis in Amsterdam she further specialized in medical oncology while performing research that resulted in her PhD degree on ‘high-dose chemotherapy in solid tumors’ in 1995. From 1995 till 2003 she held a position as medical oncologist at the department of medical oncology at the VU Medical Center in Amsterdam. During this time she spend 14 months as a basic scientist at the Sidney Kimmel Cancer Institute at Johns Hopkins Medical Institutions (JHMI) in Baltimore, USA . Following her stay at the Sidney Kimmel Cancer Institute she became part-time associate professor at JHMI which position she still helds.

In 2003 she was appointed full professor of medicine at the University Medical Center Utrecht (UMCU) and head of the specialization program in internal medicine. In addition, she became member of the management team of the Division of Internal Medicine and Dermatology of the UMCU, responsible for research and education development within the Division. In 2005, she was appointed as distinguished professor of Utrecht University. In 2007 she left the specialization program in internal medicine and became head of the Cancer Center of the UMC Utrecht. As of 2018 she was appointend chair of the Strategic Program Cancer. Her out-patient clinical activities focus entirely on patients with breast cancer. Together with prof. dr. Paul van Diest, head of the Department of Pathology, she supervises the laboratory for breast cancer research at the UMC Utrecht. The focus of her scientific research is on breast carcinogenesis and she is co-author of over 200 peer-reviewed scientific papers. Outside her regular work she holds various positions that, amongst others, include: member of the Medical Advisory Board of the Dutch Cancer Center Network and member of the Advisory Board of the Dutch Cancer Foundation.. In 2010 she was knighted by former HRM Queen Beatrix of the Netherlands, for her contribution to increase breast cancer awareness. In 2015 she received the “Corrie Herman” award, a national award to honour female medical role-models. In 2019 she was awarded with the Supervisor ( promotor) of the Year 2019.

 

Side Activities

1999 - visiting professor at the Sidney Kimmel Cancer Institute at Johns Hopkins Medical Institutions (JHMI) in Baltimore, USA
2005 - Distinguished professor of Utrecht University
2019 - vice-chair of the Advisory Board of the Dutch Cancer Foundation (KWF)
2019 - member of the Scientific Advisory Board PMC / UMC Utrecht
2020 - member of the Advisory Board of the theme Prevention of the strategic alliance EWUU
2021 - member of the Steering Committee of the UMC Utrecht Center of Excellence of the Focused Ultrasound Foundation (FUS)

Fellowship and Awards

2010 - knighted by former HRM Queen Beatrix of the Netherlands, for her contribution to increase breast cancer awareness.

2014 - Corry Hermann Award – Annual Award by the Dutch Female Medical Professionals Association

Research-grants received for over 12 m euro’s, including  from the Dutch cancer Foundation, NWO and private funds.

2019 - PhD supervisor of the year of the Graduate School of Life Sciences of the UU

Research Output (265)

The microRNA Lifecycle in Health and Cancer

de Rooij Laura Adriana, Mastebroek Dirk Jan, Ten Voorde Nicky, van der Wall Elsken, van Diest Paul Joannes, Moelans Cathy Beatrice 1 Dec 2022, In: Cancers. 14 , p. 1-36

Possible alleviation of symptoms and side effects through clinicians' nocebo information and empathy in an experimental video vignette study

Meijers M C, Stouthard J, Evers A W M, Das E, Drooger H J, Jansen S J A J, Francke A L, Plum N, van der Wall E, Nestoriuc Y, Dusseldorp E, van Vliet L M 27 Sep 2022, In: Scientific Reports. 12 , p. 1-12

Improving prediction of response to neoadjuvant treatment in patients with breast cancer by combining liquid biopsies with multiparametric MRI:Protocol of the LIMA study-a multicentre prospective observational cohort study

Janssen Liselore M., Suelmann Britt B.M., Elias Sjoerd G., Janse Markus H.A., Van Diest Paul J., Van Der Wall Elsken, Gilhuijs Kenneth G.A. 20 Sep 2022, In: BMJ Open. 12 , p. 1-8

MRI to assess response after neoadjuvant chemotherapy in breast cancer subtypes:a systematic review and meta-analysis

Janssen L. M., den Dekker B. M., Gilhuijs K. G.A., van Diest P. J., van der Wall E., Elias S. G. 19 Sep 2022, In: npj Breast Cancer. 8 , p. 1-7

Elevated miR-29c-5p Expression in Nipple Aspirate Fluid Is Associated with Extremely High Mammographic Breast Density

Vissers Tessa A C M, Piek Leonie, Patuleia Susana I S, Duinmeijer Aafke J, Bakker Marije F, van der Wall Elsken, van Diest Paul J, van Gils Carla H, Moelans Cathy B 5 Aug 2022, In: Cancers. 14 , p. 1-15

Design of a multinational randomized controlled trial to assess the effects of structured and individualized exercise in patients with metastatic breast cancer on fatigue and quality of life:the EFFECT study

Hiensch Anouk E, Monninkhof Evelyn M, Schmidt Martina E, Zopf Eva M, Bolam Kate A, Aaronson Neil K, Belloso Jon, Bloch Wilhelm, Clauss Dorothea, Depenbusch Johanna, Lachowicz Milena, Pelaez Mireia, Rundqvist Helene, Senkus Elzbieta, Stuiver Martijn M, Trevaskis Mark, Urruticoechea Ander, Rosenberger Friederike, van der Wall Elsken, de Wit G Ardine, Zimmer Philipp, Wengström Yvonne, Steindorf Karen, May Anne M 29 Jul 2022, In: Trials. 23

Genomic copy number alterations as biomarkers for triple negative pregnancy-associated breast cancer

Suelmann B B M, Rademaker A, van Dooijeweert C, van der Wall E, van Diest P J, Moelans C B 6 Jul 2022, In: Cellular oncology. 45 , p. 591-600 10 p.

Patient-centered research: how do women tolerate nipple fluid aspiration as a potential screening tool for breast cancer?

Patuleia Susana I S, Moelans Cathy B, Koopman Jasmijn, van Steenhoven Julia E C, van Dalen Thijs, van der Pol Carmen C, Jager Agnes, Ausems Margreet G E M, van Diest Paul J, van der Wall Elsken, Suijkerbuijk Karijn P M 27 Jun 2022, In: BMC Cancer. 22 , p. 1-8

Effects of structured involvement of the primary care team versus standard care after a cancer diagnosis on patient satisfaction and healthcare use:the GRIP randomised controlled trial

Perfors I. A.A., Helsper C. W., Noteboom E. A., Visserman E. A., van Dorst E. B.L., van Dalen T., Verhagen M. A.M.T., Witkamp A. J., Koelemij R., Flinterman A. E., Pruissen-Peeters K. A.B.M., Schramel F. M.N.H., van Rens M. T.M., Ernst M. F., Moons L. M.G., van der Wall E., de Wit N. J., May A. M. 4 Jun 2022, In: BMC Primary Care. 23 , p. 1-14

Effect of physical exercise on cognitive function after chemotherapy in patients with breast cancer:a randomized controlled trial (PAM study)

Koevoets E W, Schagen S B, de Ruiter M B, Geerlings M I, Witlox L, van der Wall E, Stuiver M M, Sonke G S, Velthuis M J, Jobsen J J, Menke-Pluijmers M B E, Göker E, van der Pol C C, Bos M E M M, Tick L W, van Holsteijn N A, van der Palen J, May A M, Monninkhof E M, 26 May 2022, In: Breast Cancer Research. 24

All research output

Thank you for your review!

Has this information helped you?

Please tell us why, so that we can improve our website.

Working at UMC Utrecht

Contact

Emergency?

Directions

Appointments

Practical

umcutrecht.nl maakt gebruik van cookies

Deze website maakt gebruik van cookies Deze website toont video’s van o.a. YouTube. Dergelijke partijen plaatsen cookies (third party cookies). Als u deze cookies niet wilt kunt u dat hier aangeven. Wij plaatsen zelf ook cookies om onze site te verbeteren.

Lees meer over het cookiebeleid

Akkoord Nee, liever niet